ADIAL PHARMACEUTICALS INC's ticker is ADIL and the CUSIP is 00688A106. A total of 23 filers reported holding ADIAL PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $10,890 | -40.6% | 52,354 | 0.0% | 0.00% | – |
Q1 2023 | $18,324 | -17.8% | 52,354 | -50.0% | 0.00% | – |
Q4 2022 | $22,302 | +23.9% | 104,708 | +100.0% | 0.00% | – |
Q3 2022 | $18,000 | -74.3% | 52,354 | 0.0% | 0.00% | – |
Q2 2022 | $70,000 | -33.3% | 52,354 | 0.0% | 0.00% | – |
Q1 2022 | $105,000 | -22.2% | 52,354 | +4.4% | 0.00% | – |
Q4 2021 | $135,000 | -37.2% | 50,154 | 0.0% | 0.00% | – |
Q3 2021 | $215,000 | +72.0% | 50,154 | +2.5% | 0.00% | – |
Q2 2021 | $125,000 | – | 48,954 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARMISTICE CAPITAL, LLC | 1,817,454 | $3,653,000 | 0.07% |
CSS LLC/IL | 41,300 | $83,000 | 0.00% |
Empirical Financial Services, LLC d.b.a. Empirical Wealth Management | 35,000 | $70,000 | 0.00% |
CSS LLC/IL | 33,900 | $68,000 | 0.00% |
Private Advisor Group, LLC | 34,150 | $69,000 | 0.00% |
OPPENHEIMER & CO INC | 38,500 | $77,000 | 0.00% |
High Net Worth Advisory Group LLC | 1,000 | $2,000 | 0.00% |
VANGUARD GROUP INC | 590,852 | $1,187,000 | 0.00% |
UBS Group AG | 6,840 | $14,000 | 0.00% |
OSAIC HOLDINGS, INC. | 8,321 | $25,000 | 0.00% |